Psychiatric Services
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Nasrallah, H. A.
* Articles by Ross, R.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Nasrallah, H. A.
* Articles by Ross, R.
Related Collections
* Other Health Services Issues
* Recovery
* Schizophrenia Spectrum Disorders
Psychiatr Serv 56:273-282, March 2005
© 2005 American Psychiatric Association

Defining and Measuring Clinical Effectiveness in the Treatment of Schizophrenia

Henry A. Nasrallah, M.D., Steven D. Targum, M.D., Rajiv Tandon, M.D., Jeffrey S. McCombs, Ph.D. and Ruth Ross, M.A.

OBJECTIVES: Expectations in treating schizophrenia are expanding beyond just controlling psychotic symptoms to include functional recovery. This report describes an approach to define and measure the clinical effectiveness of treatment in achieving these objectives. METHODS: A comprehensive literature review established that there is limited information about the meaning of the term "clinical effectiveness." To address this gap a consensus conference of schizophrenia researchers was held to consider the components of clinical effectiveness in real-world community practice and how these components can best be measured. RESULTS: The consensus of the researchers was that effective clinical treatment is characterized by four outcome domains: symptoms of disease, treatment burden, disease burden, and health and wellness. A clinical instrument to measure these four domains was constructed: Global Outcome Assessment of Life in Schizophrenia (GOALS). In using GOALS, clinicians rate each of the four domains on a scale of 1, very much improved, to 7, very much worse. Field-testing of this instrument is planned. CONCLUSIONS: Effective treatment interventions that combine optimal pharmacotherapy and targeted psychosocial treatments are raising expectations about the prospects of functional recovery among patients with schizophrenia. GOALS is proposed as one tool that can provide busy clinicians with a simple, objective measure of the effectiveness and outcomes of the clinical treatment they provide to patients with schizophrenia.




This article has been cited by other articles:


Home page
Scand J Public HealthHome page
A. Konu, P. Rissanen, M. Ihantola, and R. Sund
``Effectiveness'' in Finnish healthcare studies
Scand J Public Health, January 1, 2009; 37(1): 64 - 74.
[Abstract] [PDF]


Home page
Br. J. PsychiatryHome page
R. McCabe, M. Saidi, and S. Priebe
Patient-reported outcomes in schizophrenia
The British Journal of Psychiatry, August 1, 2007; 191(50): s21 - s28.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
A. S. Bellack
Scientific and Consumer Models of Recovery in Schizophrenia: Concordance, Contrasts, and Implications
Schizophr Bull, July 1, 2006; 32(3): 432 - 442.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2005 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org